Developing radionuclide PARP inhibitors
Interviewee/Contributor
Greg Mullen
Organisation
Theragnostics Ltd
A diagnostic test that identifies the correct treatment for a particular individual
© 2021 Evernow Publishing Ltd. Powered by Drupal.